E-LIB Suche - Ergebnisse für: Colbeck, Emily J.

1

Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimo..:

Amin, Oliver E. ; Colbeck, Emily J. ; Daffis, Stephane...
Hepatology. 74 (2021) 1 - p. 55-71 , 2021

Link: https://doi.org/10.1002/..

2

FRI-132-In vitro modulation by TLR8 agonist GS-9688 of mult..:

Amin, Oliver E ; Colbeck, Emily ; Daffis, Stephane...
Journal of Hepatology. 70 (2019) 1 - p. e445 , 2019

Link: https://doi.org/10.1016/..

3

IL-2high tissue-resident T cells in the human liver: Sentin..:

Pallett, Laura J. ; Davies, Jessica ; Colbeck, Emily J....
Journal of Experimental Medicine. 214 (2017) 6 - p. 1567-1580 , 2017

Link: https://doi.org/10.1084/..

4

A distinct chemokine axis does not account for enrichment o..:

Ondondo, Beatrice ; Colbeck, Emily ; Jones, Emma...
Immunology. 145 (2015) 1 - p. 94-104 , 2015

Link: https://doi.org/10.1111/..

5

Eliminating roles for T-bet and IL-2 but revealing superior..:

Colbeck, Emily J. ; Hindley, James P. ; Smart, Kathryn...
Oncotarget. 6 (2015) 28 - p. 24649-24659 , 2015

Link: https://doi.org/10.18632..

6

Evolution of the Retroviral Restriction Gene Fv1: Inhibitio..:

Yap, Melvyn W. ; Colbeck, Emily ; Ellis, Scott A...
PLoS Pathogens. 10 (2014) 3 - p. e1003968 , 2014

Link: https://doi.org/10.1371/..

7

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumo..:

Colbeck, Emily Jayne ; Ager, Ann ; Gallimore, Awen.
Frontiers in Immunology. 8 (2017) - p. , 2017

Link: https://doi.org/10.3389/..

8

IL-2high tissue-resident T cells in the human liver: Sentin..:

Pallett, Laura J ; Davies, Jessica ; Colbeck, Emily J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461007/. , 2017

Link: http://www.ncbi.nlm.nih...

9

Treg Depletion Licenses T Cell–Driven HEV Neogenesis and Pr..:

Colbeck, Emily J ; Jones, Emma ; Hindley, James P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668144/. , 2017

Link: http://www.ncbi.nlm.nih...

10

A distinct chemokine axis does not account for enrichment o..:

Ondondo, Beatrice ; Colbeck, Emily ; Jones, Emma...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405327/. , 2015

Link: http://www.ncbi.nlm.nih...

11

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumo..:

Colbeck, Emily Jayne ; Ager, Ann ; Gallimore, Awen.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742143/. , 2017

Link: http://www.ncbi.nlm.nih...

12

Tertiary Lymphoid Structures in Cancer:Drivers of Antitumor..:

Colbeck, Emily Jayne ; Ager, Ann ; Gallimore, Awen.
Colbeck , E J , Ager , A , Gallimore , A & Jones , G W 2017 , ' Tertiary Lymphoid Structures in Cancer : Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease? ' , Frontiers in Immunology , vol. 8 , 1830 . https://doi.org/10.3389/fimmu.2017.01830. , 2017

Link: https://hdl.handle.net/1..

13

Evolution of the retroviral restriction gene Fv1: inhibitio..:

Melvyn W Yap ; Emily Colbeck ; Scott A Ellis.
http://europepmc.org/articles/PMC3948346?pdf=render. , 2014

Link: https://doi.org/10.1371/..

14

Smoking cessation for people with severe mental illness (SC..:

Gilbody, Simon ; Peckham, Emily ; Bailey, Della...
The Lancet Psychiatry. 6 (2019) 5 - p. 379-390 , 2019

Link: https://doi.org/10.1016/..

15

Tertiary Lymphoid Structures in Cancer: Drivers of Antitumo..:

Emily Jayne Colbeck ; Ann Ager ; Awen Gallimore.
http://journal.frontiersin.org/article/10.3389/fimmu.2017.01830/full. , 2017

Link: https://doi.org/10.3389/..